Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shimpei Matsumi

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Internal Medicine (Tokyo, Japan)|September 27, 2019
Erdheim-Chester DiseaseShinya Yamamoto, Shimpei Matsumi, Shinichi Teshima
International Journal of Hematology|November 1, 2022
Very early death within 30 days after diagnosis in patients with acute myeloid leukemiaMachiko Kusuda, Hideki Nakasone, Yuhei Nakamura, et al.
Bone Marrow Transplantation|June 6, 2022
Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantationMasaharu Tamaki, Shimpei Matsumi, Hideki Nakasone, et al.
International Journal of Hematology|January 6, 2022
Emergence of clone with PHF6 nonsense mutation in chronic myelomonocytic leukemia at relapse after allogeneic HCTYu Akahoshi, Hideki Nakasone, Machiko Kusuda, et al.
Transplantation and Cellular Therapy|May 13, 2021
Prediction of Cytomegalovirus Reactivation by Recipient Cytomegalovirus-IgG Titer before Allogeneic Hematopoietic Stem Cell TransplantationShunto Kawamura, Hideki Nakasone, Junko Takeshita, et al.
Acta Haematologica|May 23, 2022
Successful Treatment of the TEMPI Syndrome with Pomalidomide Plus Dexamethasone Followed by Autologous Stem Cell TransplantationShunto Kawamura, Masaharu Tamaki, Yuhei Nakamura, et al.
Transplantation and Cellular Therapy|June 24, 2022
Low-Intensity Immunosuppressive Therapy for Chronic Graft-versus-Host DiseaseKazuki Yoshimura, Shun-Ichi Kimura, Hideki Nakasone, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 26, 2021
Association between the kinetics of cytomegalovirus reactivation in terms of the area under the curve of cytomegalovirus antigenemia and non-relapse mortality after allogeneic hematopoietic stem cell transplantationJunko Takeshita, Shun-Ichi Kimura, Hideki Nakasone, et al.
Leukemia & Lymphoma|April 7, 2022
Risk factors and outcomes of definite or clinical idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantationMasaharu Tamaki, Hideki Nakasone, Yuhei Nakamura, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 7, 2020
Association of the areas over and under the lymphocyte curve with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantationShun-Ichi Kimura, Yuhei Nakamura, Masakatsu Kawamura, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Internal Medicine (Tokyo, Japan)|September 27, 2019
Erdheim-Chester DiseaseShinya Yamamoto, Shimpei Matsumi, Shinichi Teshima
International Journal of Hematology|November 1, 2022
Very early death within 30 days after diagnosis in patients with acute myeloid leukemiaMachiko Kusuda, Hideki Nakasone, Yuhei Nakamura, et al.
Bone Marrow Transplantation|June 6, 2022
Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantationMasaharu Tamaki, Shimpei Matsumi, Hideki Nakasone, et al.
International Journal of Hematology|January 6, 2022
Emergence of clone with PHF6 nonsense mutation in chronic myelomonocytic leukemia at relapse after allogeneic HCTYu Akahoshi, Hideki Nakasone, Machiko Kusuda, et al.
Transplantation and Cellular Therapy|May 13, 2021
Prediction of Cytomegalovirus Reactivation by Recipient Cytomegalovirus-IgG Titer before Allogeneic Hematopoietic Stem Cell TransplantationShunto Kawamura, Hideki Nakasone, Junko Takeshita, et al.
Acta Haematologica|May 23, 2022
Successful Treatment of the TEMPI Syndrome with Pomalidomide Plus Dexamethasone Followed by Autologous Stem Cell TransplantationShunto Kawamura, Masaharu Tamaki, Yuhei Nakamura, et al.
Transplantation and Cellular Therapy|June 24, 2022
Low-Intensity Immunosuppressive Therapy for Chronic Graft-versus-Host DiseaseKazuki Yoshimura, Shun-Ichi Kimura, Hideki Nakasone, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 26, 2021
Association between the kinetics of cytomegalovirus reactivation in terms of the area under the curve of cytomegalovirus antigenemia and non-relapse mortality after allogeneic hematopoietic stem cell transplantationJunko Takeshita, Shun-Ichi Kimura, Hideki Nakasone, et al.
Leukemia & Lymphoma|April 7, 2022
Risk factors and outcomes of definite or clinical idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantationMasaharu Tamaki, Hideki Nakasone, Yuhei Nakamura, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 7, 2020
Association of the areas over and under the lymphocyte curve with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantationShun-Ichi Kimura, Yuhei Nakamura, Masakatsu Kawamura, et al.
Pageof 2